Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 103 issues

Getting Prolastin-C Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization, Appeals, and State External Review

Answer Box: Prolastin-C Coverage with Blue Cross Blue Shield in Virginia Blue Cross Blue Shield Virginia requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) for alpha-1 antitrypsin deficiency. Coverage requires documented severe AATD (like Pi*ZZ genotype), clinical evidence of emphysema, and lung function tests showing moderate impairment (typically FEV1 35-60%
5 min read

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Blue Cross Blue Shield in Illinois: Complete Guide with Forms and Appeal Scripts

Answer Box: To get Upstaza (eladocagene exuparvovec) covered by Blue Cross Blue Shield of Illinois, you need: (1) confirmed AADC deficiency diagnosis with genetic testing, (2) prior authorization through the BCBSIL specialty drug portal, and (3) documentation from a certified gene therapy center. Start by gathering genetic test results and
5 min read

How to Get Spinraza (nusinersen) Covered by Blue Cross Blue Shield of Texas: Prior Authorization, Appeals & Success Strategies

Answer Box: Getting Spinraza Covered by BCBS Texas Spinraza (nusinersen) requires prior authorization from Blue Cross Blue Shield of Texas before coverage begins. The fastest path to approval involves three key steps: 1) Have your neurologist submit comprehensive medical documentation through the Availity Portal, including genetic SMA confirmation and baseline
6 min read

How to Get Onpattro (patisiran) Covered by Blue Cross Blue Shield in Florida: Complete Guide with Forms and Appeal Templates

Answer Box: Getting Onpattro Covered in Florida Eligibility: Blue Cross Blue Shield Florida covers Onpattro (patisiran) for hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults 18+ with confirmed TTR gene mutation and specialist evaluation. Fastest path: Gather genetic testing, neurologist consultation, and baseline scores (mNIS+7, 6MWT) before submitting prior
5 min read

Myths vs. Facts: Getting Koselugo (Selumetinib) Covered by Blue Cross Blue Shield in Michigan - Appeals Guide 2025

Answer Box: Getting Koselugo Covered in Michigan Eligibility: Blue Cross Blue Shield of Michigan covers Koselugo for pediatric patients (ages 2-18) with NF1 and symptomatic, inoperable plexiform neurofibromas requiring prior authorization. Fastest Path: Submit complete PA with baseline LVEF (echocardiogram), ophthalmologic exam, NF1 diagnosis confirmation, and tumor imaging showing inoperability.
5 min read

If Keytruda Isn't Approved by Blue Cross Blue Shield in Texas: Formulary Alternatives & Exception Paths

Quick Answer: If Blue Cross Blue Shield of Texas denies Keytruda (pembrolizumab), formulary alternatives include Opdivo (nivolumab), Tecentriq (atezolizumab), Imfinzi (durvalumab), and Libtayo (cemiplimab). Submit a Prescription Drug Coverage Exception form with detailed medical documentation showing why preferred drugs failed or are contraindicated. Internal appeals have 72-hour decisions, with external
6 min read